Eritrea's blueprint for trachoma elimination: A home-grown model for sustainable impact.

IF 4.8 2区医学 Q1 INFECTIOUS DISEASES

International Journal of Infectious Diseases Pub Date : 2025-01-31 DOI:10.1016/j.ijid.2025.107814

Gilbert Baayenda, Martha Mberu, Sarity Dodson, Kelly Zongo, Jackline Syonguvi, Jeremiah Ngondi, Alem Zecarias

{"title":"Eritrea's blueprint for trachoma elimination: A home-grown model for sustainable impact.","authors":"Gilbert Baayenda, Martha Mberu, Sarity Dodson, Kelly Zongo, Jackline Syonguvi, Jeremiah Ngondi, Alem Zecarias","doi":"10.1016/j.ijid.2025.107814","DOIUrl":null,"url":null,"abstract":"Purpose: This overview highlights Eritrea's progress in trachoma elimination from 2006 to 2024, emphasizing the Surgery, Antibiotics, Facial Cleanliness and Environmental Improvement (SAFE) strategy, pillars of the Neglected Tropical Diseases (NTD) Roadmap, and geostatistical mapping's role in achieving elimination targets.Methods: Trachoma Impact Surveys (TIS) and Surveillance Surveys (TSS) monitored WHO-endorsed SAFE strategy interventions and progress, with model-based geo-statistics providing more precise prevalence estimates.Results: Eritrea has attained open defecation-free status in 93% of villages, performed 22,546 Trachomatous Trachiasis (TT) surgeries, and integrated surveillance data into the District Health Information System (DHIS2). TT prevalence among those 15 years and older has significantly decreased, with many areas below the World Health Organization (WHO) threshold of 0.2%. Eritrea reduced TF prevalence among children aged 1 to 9 years from over 10% in 2006 to less than 5% in 2022, and TT prevalence among adults aged 15 and older from 3% to below 0.2% in most regions.Conclusion: Eritrea's innovative approaches and strong partnerships provide a model for other countries facing NTDs. Reliable data have been crucial for targeting resources and monitoring progress toward trachoma elimination.","PeriodicalId":14006,"journal":{"name":"International Journal of Infectious Diseases","volume":" ","pages":"107814"},"PeriodicalIF":4.8000,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijid.2025.107814","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: This overview highlights Eritrea's progress in trachoma elimination from 2006 to 2024, emphasizing the Surgery, Antibiotics, Facial Cleanliness and Environmental Improvement (SAFE) strategy, pillars of the Neglected Tropical Diseases (NTD) Roadmap, and geostatistical mapping's role in achieving elimination targets.

Methods: Trachoma Impact Surveys (TIS) and Surveillance Surveys (TSS) monitored WHO-endorsed SAFE strategy interventions and progress, with model-based geo-statistics providing more precise prevalence estimates.

Results: Eritrea has attained open defecation-free status in 93% of villages, performed 22,546 Trachomatous Trachiasis (TT) surgeries, and integrated surveillance data into the District Health Information System (DHIS2). TT prevalence among those 15 years and older has significantly decreased, with many areas below the World Health Organization (WHO) threshold of 0.2%. Eritrea reduced TF prevalence among children aged 1 to 9 years from over 10% in 2006 to less than 5% in 2022, and TT prevalence among adults aged 15 and older from 3% to below 0.2% in most regions.

Conclusion: Eritrea's innovative approaches and strong partnerships provide a model for other countries facing NTDs. Reliable data have been crucial for targeting resources and monitoring progress toward trachoma elimination.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Infectious Diseases 医学-传染病学

CiteScore

18.90

自引率

2.40%

发文量

1020

审稿时长

30 days

期刊介绍： International Journal of Infectious Diseases (IJID) Publisher: International Society for Infectious Diseases Publication Frequency: Monthly Type: Peer-reviewed, Open Access Scope: Publishes original clinical and laboratory-based research. Reports clinical trials, reviews, and some case reports. Focuses on epidemiology, clinical diagnosis, treatment, and control of infectious diseases. Emphasizes diseases common in under-resourced countries.